nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—CYP3A4—Thiotepa—sarcoma	0.111	0.458	CbGbCtD
Hydralazine—CYP3A4—Mitoxantrone—sarcoma	0.0478	0.197	CbGbCtD
Hydralazine—CYP3A4—Vincristine—sarcoma	0.0329	0.136	CbGbCtD
Hydralazine—CYP3A4—Etoposide—sarcoma	0.0301	0.124	CbGbCtD
Hydralazine—AOC3—endothelium—sarcoma	0.0232	0.0664	CbGeAlD
Hydralazine—RYR2—myometrium—sarcoma	0.022	0.0631	CbGeAlD
Hydralazine—CYP3A4—Doxorubicin—sarcoma	0.0206	0.0847	CbGbCtD
Hydralazine—RYR2—seminal vesicle—sarcoma	0.0199	0.057	CbGeAlD
Hydralazine—AOC3—mammary gland—sarcoma	0.0187	0.0536	CbGeAlD
Hydralazine—RYR2—smooth muscle tissue—sarcoma	0.0166	0.0477	CbGeAlD
Hydralazine—RYR2—cardiac atrium—sarcoma	0.0143	0.0412	CbGeAlD
Hydralazine—RYR2—uterus—sarcoma	0.0143	0.0409	CbGeAlD
Hydralazine—AOC3—myometrium—sarcoma	0.0132	0.038	CbGeAlD
Hydralazine—AOC3—seminal vesicle—sarcoma	0.012	0.0343	CbGeAlD
Hydralazine—AOC3—hematopoietic system—sarcoma	0.0114	0.0326	CbGeAlD
Hydralazine—AOC3—connective tissue—sarcoma	0.011	0.0314	CbGeAlD
Hydralazine—P4HA1—myometrium—sarcoma	0.0106	0.0304	CbGeAlD
Hydralazine—RYR2—testis—sarcoma	0.0104	0.0297	CbGeAlD
Hydralazine—AOC3—smooth muscle tissue—sarcoma	0.01	0.0287	CbGeAlD
Hydralazine—P4HA1—seminal vesicle—sarcoma	0.00957	0.0274	CbGeAlD
Hydralazine—P4HA1—hematopoietic system—sarcoma	0.00909	0.0261	CbGeAlD
Hydralazine—P4HA1—connective tissue—sarcoma	0.00876	0.0251	CbGeAlD
Hydralazine—AOC3—cardiac atrium—sarcoma	0.00864	0.0248	CbGeAlD
Hydralazine—AOC3—uterus—sarcoma	0.00859	0.0246	CbGeAlD
Hydralazine—P4HA1—smooth muscle tissue—sarcoma	0.00801	0.023	CbGeAlD
Hydralazine—AOC3—lymphoid tissue—sarcoma	0.00801	0.023	CbGeAlD
Hydralazine—AOC3—tendon—sarcoma	0.00753	0.0216	CbGeAlD
Hydralazine—AOC3—bone marrow—sarcoma	0.00729	0.0209	CbGeAlD
Hydralazine—P4HA1—cardiac atrium—sarcoma	0.00691	0.0198	CbGeAlD
Hydralazine—P4HA1—uterus—sarcoma	0.00687	0.0197	CbGeAlD
Hydralazine—P4HA1—lymphoid tissue—sarcoma	0.0064	0.0184	CbGeAlD
Hydralazine—AOC3—testis—sarcoma	0.00623	0.0179	CbGeAlD
Hydralazine—P4HA1—tendon—sarcoma	0.00602	0.0173	CbGeAlD
Hydralazine—AOC3—liver—sarcoma	0.00589	0.0169	CbGeAlD
Hydralazine—P4HA1—bone marrow—sarcoma	0.00583	0.0167	CbGeAlD
Hydralazine—P4HA1—testis—sarcoma	0.00498	0.0143	CbGeAlD
Hydralazine—P4HA1—liver—sarcoma	0.00471	0.0135	CbGeAlD
Hydralazine—AOC3—lymph node—sarcoma	0.00452	0.013	CbGeAlD
Hydralazine—P4HA1—lymph node—sarcoma	0.00361	0.0104	CbGeAlD
Hydralazine—CYP3A4—hematopoietic system—sarcoma	0.00241	0.00692	CbGeAlD
Hydralazine—Hypoaesthesia—Vincristine—sarcoma	0.00186	0.00455	CcSEcCtD
Hydralazine—Lacrimation increased—Epirubicin—sarcoma	0.00183	0.00448	CcSEcCtD
Hydralazine—Hepatitis—Mitoxantrone—sarcoma	0.00182	0.00445	CcSEcCtD
Hydralazine—Pancytopenia—Etoposide—sarcoma	0.0018	0.00439	CcSEcCtD
Hydralazine—Neutropenia—Etoposide—sarcoma	0.00177	0.00432	CcSEcCtD
Hydralazine—Lacrimation increased—Doxorubicin—sarcoma	0.0017	0.00415	CcSEcCtD
Hydralazine—Anaemia—Thiotepa—sarcoma	0.00169	0.00414	CcSEcCtD
Hydralazine—Ill-defined disorder—Dactinomycin—sarcoma	0.00169	0.00413	CcSEcCtD
Hydralazine—Agitation—Thiotepa—sarcoma	0.00168	0.00412	CcSEcCtD
Hydralazine—Anaemia—Dactinomycin—sarcoma	0.00168	0.00411	CcSEcCtD
Hydralazine—Neuropathy peripheral—Etoposide—sarcoma	0.00165	0.00404	CcSEcCtD
Hydralazine—Jaundice—Etoposide—sarcoma	0.00164	0.00402	CcSEcCtD
Hydralazine—Leukopenia—Thiotepa—sarcoma	0.00164	0.00401	CcSEcCtD
Hydralazine—Malaise—Dactinomycin—sarcoma	0.00164	0.00401	CcSEcCtD
Hydralazine—Chills—Mitoxantrone—sarcoma	0.00163	0.00399	CcSEcCtD
Hydralazine—Leukopenia—Dactinomycin—sarcoma	0.00163	0.00398	CcSEcCtD
Hydralazine—Agranulocytosis—Etoposide—sarcoma	0.00157	0.00385	CcSEcCtD
Hydralazine—Arthralgia—Thiotepa—sarcoma	0.00156	0.00382	CcSEcCtD
Hydralazine—Myalgia—Thiotepa—sarcoma	0.00156	0.00382	CcSEcCtD
Hydralazine—Anxiety—Thiotepa—sarcoma	0.00156	0.0038	CcSEcCtD
Hydralazine—Myalgia—Dactinomycin—sarcoma	0.00155	0.00379	CcSEcCtD
Hydralazine—Discomfort—Dactinomycin—sarcoma	0.00153	0.00374	CcSEcCtD
Hydralazine—Hypoaesthesia—Etoposide—sarcoma	0.00151	0.00368	CcSEcCtD
Hydralazine—Anaemia—Vincristine—sarcoma	0.0015	0.00368	CcSEcCtD
Hydralazine—Agitation—Vincristine—sarcoma	0.00149	0.00365	CcSEcCtD
Hydralazine—Oedema—Dactinomycin—sarcoma	0.00149	0.00363	CcSEcCtD
Hydralazine—Ill-defined disorder—Mitoxantrone—sarcoma	0.00147	0.00359	CcSEcCtD
Hydralazine—Thrombocytopenia—Thiotepa—sarcoma	0.00147	0.00358	CcSEcCtD
Hydralazine—Anaemia—Mitoxantrone—sarcoma	0.00146	0.00358	CcSEcCtD
Hydralazine—Tachycardia—Thiotepa—sarcoma	0.00146	0.00357	CcSEcCtD
Hydralazine—Leukopenia—Vincristine—sarcoma	0.00146	0.00356	CcSEcCtD
Hydralazine—Thrombocytopenia—Dactinomycin—sarcoma	0.00145	0.00356	CcSEcCtD
Hydralazine—Lymphadenopathy—Epirubicin—sarcoma	0.00144	0.00351	CcSEcCtD
Hydralazine—Malaise—Mitoxantrone—sarcoma	0.00143	0.00349	CcSEcCtD
Hydralazine—Anorexia—Thiotepa—sarcoma	0.00143	0.00349	CcSEcCtD
Hydralazine—Leukopenia—Mitoxantrone—sarcoma	0.00142	0.00347	CcSEcCtD
Hydralazine—Anorexia—Dactinomycin—sarcoma	0.00142	0.00346	CcSEcCtD
Hydralazine—Flushing—Etoposide—sarcoma	0.0014	0.00343	CcSEcCtD
Hydralazine—Hepatic function abnormal—Epirubicin—sarcoma	0.0014	0.00343	CcSEcCtD
Hydralazine—Myalgia—Vincristine—sarcoma	0.00138	0.00339	CcSEcCtD
Hydralazine—Vascular purpura—Epirubicin—sarcoma	0.00137	0.00335	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00136	0.00333	CcSEcCtD
Hydralazine—Chills—Etoposide—sarcoma	0.00136	0.00332	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00135	0.00331	CcSEcCtD
Hydralazine—Cardiac failure congestive—Epirubicin—sarcoma	0.00135	0.00331	CcSEcCtD
Hydralazine—Arthralgia—Mitoxantrone—sarcoma	0.00135	0.0033	CcSEcCtD
Hydralazine—Myalgia—Mitoxantrone—sarcoma	0.00135	0.0033	CcSEcCtD
Hydralazine—Paraesthesia—Thiotepa—sarcoma	0.00134	0.00329	CcSEcCtD
Hydralazine—Anxiety—Mitoxantrone—sarcoma	0.00134	0.00329	CcSEcCtD
Hydralazine—Discomfort—Mitoxantrone—sarcoma	0.00133	0.00326	CcSEcCtD
Hydralazine—Lymphadenopathy—Doxorubicin—sarcoma	0.00133	0.00325	CcSEcCtD
Hydralazine—Renal failure acute—Epirubicin—sarcoma	0.00133	0.00325	CcSEcCtD
Hydralazine—Oedema—Vincristine—sarcoma	0.00133	0.00325	CcSEcCtD
Hydralazine—Dyspepsia—Thiotepa—sarcoma	0.00132	0.00322	CcSEcCtD
Hydralazine—Decreased appetite—Thiotepa—sarcoma	0.0013	0.00318	CcSEcCtD
Hydralazine—Thrombocytopenia—Vincristine—sarcoma	0.0013	0.00318	CcSEcCtD
Hydralazine—Hepatic function abnormal—Doxorubicin—sarcoma	0.0013	0.00317	CcSEcCtD
Hydralazine—Oedema—Mitoxantrone—sarcoma	0.00129	0.00316	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00129	0.00316	CcSEcCtD
Hydralazine—Decreased appetite—Dactinomycin—sarcoma	0.00129	0.00316	CcSEcCtD
Hydralazine—Constipation—Thiotepa—sarcoma	0.00128	0.00313	CcSEcCtD
Hydralazine—Purpura—Epirubicin—sarcoma	0.00127	0.00311	CcSEcCtD
Hydralazine—Vascular purpura—Doxorubicin—sarcoma	0.00127	0.0031	CcSEcCtD
Hydralazine—Muscle spasms—Etoposide—sarcoma	0.00127	0.0031	CcSEcCtD
Hydralazine—Thrombocytopenia—Mitoxantrone—sarcoma	0.00127	0.00309	CcSEcCtD
Hydralazine—Anorexia—Vincristine—sarcoma	0.00126	0.00309	CcSEcCtD
Hydralazine—Tachycardia—Mitoxantrone—sarcoma	0.00126	0.00308	CcSEcCtD
Hydralazine—Cardiac failure—Epirubicin—sarcoma	0.00126	0.00307	CcSEcCtD
Hydralazine—Cardiac failure congestive—Doxorubicin—sarcoma	0.00125	0.00306	CcSEcCtD
Hydralazine—CYP3A4—liver—sarcoma	0.00125	0.00358	CbGeAlD
Hydralazine—Hypotension—Vincristine—sarcoma	0.00124	0.00303	CcSEcCtD
Hydralazine—Feeling abnormal—Thiotepa—sarcoma	0.00123	0.00302	CcSEcCtD
Hydralazine—Anorexia—Mitoxantrone—sarcoma	0.00123	0.00301	CcSEcCtD
Hydralazine—Renal failure acute—Doxorubicin—sarcoma	0.00123	0.00301	CcSEcCtD
Hydralazine—Feeling abnormal—Dactinomycin—sarcoma	0.00122	0.00299	CcSEcCtD
Hydralazine—Ill-defined disorder—Etoposide—sarcoma	0.00122	0.00299	CcSEcCtD
Hydralazine—Anaemia—Etoposide—sarcoma	0.00122	0.00298	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Vincristine—sarcoma	0.00121	0.00296	CcSEcCtD
Hydralazine—Hypotension—Mitoxantrone—sarcoma	0.00121	0.00295	CcSEcCtD
Hydralazine—Paraesthesia—Vincristine—sarcoma	0.00119	0.00291	CcSEcCtD
Hydralazine—Urticaria—Thiotepa—sarcoma	0.00119	0.00291	CcSEcCtD
Hydralazine—Malaise—Etoposide—sarcoma	0.00119	0.00291	CcSEcCtD
Hydralazine—Body temperature increased—Thiotepa—sarcoma	0.00118	0.00289	CcSEcCtD
Hydralazine—Leukopenia—Etoposide—sarcoma	0.00118	0.00288	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00118	0.00288	CcSEcCtD
Hydralazine—Purpura—Doxorubicin—sarcoma	0.00118	0.00288	CcSEcCtD
Hydralazine—Body temperature increased—Dactinomycin—sarcoma	0.00117	0.00287	CcSEcCtD
Hydralazine—Cardiac failure—Doxorubicin—sarcoma	0.00116	0.00284	CcSEcCtD
Hydralazine—Paraesthesia—Mitoxantrone—sarcoma	0.00116	0.00284	CcSEcCtD
Hydralazine—Decreased appetite—Vincristine—sarcoma	0.00115	0.00282	CcSEcCtD
Hydralazine—Dyspnoea—Mitoxantrone—sarcoma	0.00115	0.00282	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Vincristine—sarcoma	0.00115	0.0028	CcSEcCtD
Hydralazine—Dyspepsia—Mitoxantrone—sarcoma	0.00114	0.00278	CcSEcCtD
Hydralazine—Constipation—Vincristine—sarcoma	0.00113	0.00278	CcSEcCtD
Hydralazine—Decreased appetite—Mitoxantrone—sarcoma	0.00112	0.00275	CcSEcCtD
Hydralazine—Discomfort—Etoposide—sarcoma	0.00111	0.00271	CcSEcCtD
Hydralazine—Constipation—Mitoxantrone—sarcoma	0.00111	0.0027	CcSEcCtD
Hydralazine—Hypersensitivity—Thiotepa—sarcoma	0.0011	0.0027	CcSEcCtD
Hydralazine—Hypersensitivity—Dactinomycin—sarcoma	0.00109	0.00268	CcSEcCtD
Hydralazine—Feeling abnormal—Mitoxantrone—sarcoma	0.00106	0.0026	CcSEcCtD
Hydralazine—Pruritus—Thiotepa—sarcoma	0.00106	0.00259	CcSEcCtD
Hydralazine—Thrombocytopenia—Etoposide—sarcoma	0.00105	0.00257	CcSEcCtD
Hydralazine—Tachycardia—Etoposide—sarcoma	0.00105	0.00257	CcSEcCtD
Hydralazine—Eosinophilia—Epirubicin—sarcoma	0.00105	0.00257	CcSEcCtD
Hydralazine—Body temperature increased—Vincristine—sarcoma	0.00105	0.00257	CcSEcCtD
Hydralazine—Angina pectoris—Epirubicin—sarcoma	0.00103	0.00252	CcSEcCtD
Hydralazine—Urticaria—Mitoxantrone—sarcoma	0.00103	0.00251	CcSEcCtD
Hydralazine—Anorexia—Etoposide—sarcoma	0.00102	0.00251	CcSEcCtD
Hydralazine—Diarrhoea—Thiotepa—sarcoma	0.00102	0.0025	CcSEcCtD
Hydralazine—Body temperature increased—Mitoxantrone—sarcoma	0.00102	0.0025	CcSEcCtD
Hydralazine—Diarrhoea—Dactinomycin—sarcoma	0.00102	0.00249	CcSEcCtD
Hydralazine—Pancytopenia—Epirubicin—sarcoma	0.00101	0.00246	CcSEcCtD
Hydralazine—Hypotension—Etoposide—sarcoma	0.001	0.00246	CcSEcCtD
Hydralazine—Neutropenia—Epirubicin—sarcoma	0.000991	0.00242	CcSEcCtD
Hydralazine—Dysuria—Epirubicin—sarcoma	0.000991	0.00242	CcSEcCtD
Hydralazine—Dizziness—Thiotepa—sarcoma	0.00099	0.00242	CcSEcCtD
Hydralazine—Hypersensitivity—Vincristine—sarcoma	0.000978	0.00239	CcSEcCtD
Hydralazine—Eosinophilia—Doxorubicin—sarcoma	0.000971	0.00237	CcSEcCtD
Hydralazine—Paraesthesia—Etoposide—sarcoma	0.000965	0.00236	CcSEcCtD
Hydralazine—Weight decreased—Epirubicin—sarcoma	0.000959	0.00234	CcSEcCtD
Hydralazine—Dyspnoea—Etoposide—sarcoma	0.000958	0.00234	CcSEcCtD
Hydralazine—Angina pectoris—Doxorubicin—sarcoma	0.000955	0.00234	CcSEcCtD
Hydralazine—Hypersensitivity—Mitoxantrone—sarcoma	0.000952	0.00233	CcSEcCtD
Hydralazine—Vomiting—Thiotepa—sarcoma	0.000951	0.00233	CcSEcCtD
Hydralazine—Vomiting—Dactinomycin—sarcoma	0.000944	0.00231	CcSEcCtD
Hydralazine—Rash—Thiotepa—sarcoma	0.000944	0.00231	CcSEcCtD
Hydralazine—Dermatitis—Thiotepa—sarcoma	0.000943	0.00231	CcSEcCtD
Hydralazine—Headache—Thiotepa—sarcoma	0.000937	0.00229	CcSEcCtD
Hydralazine—Rash—Dactinomycin—sarcoma	0.000936	0.00229	CcSEcCtD
Hydralazine—Decreased appetite—Etoposide—sarcoma	0.000934	0.00229	CcSEcCtD
Hydralazine—Pancytopenia—Doxorubicin—sarcoma	0.000931	0.00228	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Etoposide—sarcoma	0.000928	0.00227	CcSEcCtD
Hydralazine—Neuropathy peripheral—Epirubicin—sarcoma	0.000926	0.00227	CcSEcCtD
Hydralazine—Jaundice—Epirubicin—sarcoma	0.000921	0.00225	CcSEcCtD
Hydralazine—Constipation—Etoposide—sarcoma	0.000919	0.00225	CcSEcCtD
Hydralazine—Conjunctivitis—Epirubicin—sarcoma	0.000918	0.00225	CcSEcCtD
Hydralazine—Neutropenia—Doxorubicin—sarcoma	0.000917	0.00224	CcSEcCtD
Hydralazine—Dysuria—Doxorubicin—sarcoma	0.000917	0.00224	CcSEcCtD
Hydralazine—Diarrhoea—Vincristine—sarcoma	0.000908	0.00222	CcSEcCtD
Hydralazine—Haematuria—Epirubicin—sarcoma	0.000901	0.0022	CcSEcCtD
Hydralazine—Nausea—Thiotepa—sarcoma	0.000889	0.00217	CcSEcCtD
Hydralazine—Weight decreased—Doxorubicin—sarcoma	0.000887	0.00217	CcSEcCtD
Hydralazine—Feeling abnormal—Etoposide—sarcoma	0.000886	0.00217	CcSEcCtD
Hydralazine—Diarrhoea—Mitoxantrone—sarcoma	0.000884	0.00216	CcSEcCtD
Hydralazine—Nausea—Dactinomycin—sarcoma	0.000882	0.00216	CcSEcCtD
Hydralazine—Agranulocytosis—Epirubicin—sarcoma	0.000882	0.00216	CcSEcCtD
Hydralazine—Dizziness—Vincristine—sarcoma	0.000877	0.00215	CcSEcCtD
Hydralazine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000857	0.0021	CcSEcCtD
Hydralazine—Urticaria—Etoposide—sarcoma	0.000854	0.00209	CcSEcCtD
Hydralazine—Jaundice—Doxorubicin—sarcoma	0.000852	0.00208	CcSEcCtD
Hydralazine—Body temperature increased—Etoposide—sarcoma	0.00085	0.00208	CcSEcCtD
Hydralazine—Conjunctivitis—Doxorubicin—sarcoma	0.00085	0.00208	CcSEcCtD
Hydralazine—Hepatitis—Epirubicin—sarcoma	0.000848	0.00207	CcSEcCtD
Hydralazine—Hypoaesthesia—Epirubicin—sarcoma	0.000844	0.00206	CcSEcCtD
Hydralazine—Vomiting—Vincristine—sarcoma	0.000844	0.00206	CcSEcCtD
Hydralazine—Rash—Vincristine—sarcoma	0.000837	0.00205	CcSEcCtD
Hydralazine—Dermatitis—Vincristine—sarcoma	0.000836	0.00204	CcSEcCtD
Hydralazine—Haematuria—Doxorubicin—sarcoma	0.000833	0.00204	CcSEcCtD
Hydralazine—Headache—Vincristine—sarcoma	0.000831	0.00203	CcSEcCtD
Hydralazine—Vomiting—Mitoxantrone—sarcoma	0.000822	0.00201	CcSEcCtD
Hydralazine—Agranulocytosis—Doxorubicin—sarcoma	0.000816	0.002	CcSEcCtD
Hydralazine—Rash—Mitoxantrone—sarcoma	0.000815	0.00199	CcSEcCtD
Hydralazine—Dermatitis—Mitoxantrone—sarcoma	0.000814	0.00199	CcSEcCtD
Hydralazine—Headache—Mitoxantrone—sarcoma	0.00081	0.00198	CcSEcCtD
Hydralazine—Hypersensitivity—Etoposide—sarcoma	0.000792	0.00194	CcSEcCtD
Hydralazine—Nausea—Vincristine—sarcoma	0.000788	0.00193	CcSEcCtD
Hydralazine—Flushing—Epirubicin—sarcoma	0.000787	0.00193	CcSEcCtD
Hydralazine—Hepatitis—Doxorubicin—sarcoma	0.000785	0.00192	CcSEcCtD
Hydralazine—Hypoaesthesia—Doxorubicin—sarcoma	0.000781	0.00191	CcSEcCtD
Hydralazine—Nausea—Mitoxantrone—sarcoma	0.000768	0.00188	CcSEcCtD
Hydralazine—Chills—Epirubicin—sarcoma	0.000761	0.00186	CcSEcCtD
Hydralazine—Pruritus—Etoposide—sarcoma	0.00076	0.00186	CcSEcCtD
Hydralazine—Diarrhoea—Etoposide—sarcoma	0.000735	0.0018	CcSEcCtD
Hydralazine—Flushing—Doxorubicin—sarcoma	0.000728	0.00178	CcSEcCtD
Hydralazine—Dizziness—Etoposide—sarcoma	0.000711	0.00174	CcSEcCtD
Hydralazine—Muscle spasms—Epirubicin—sarcoma	0.00071	0.00174	CcSEcCtD
Hydralazine—Chills—Doxorubicin—sarcoma	0.000704	0.00172	CcSEcCtD
Hydralazine—Ill-defined disorder—Epirubicin—sarcoma	0.000685	0.00168	CcSEcCtD
Hydralazine—Vomiting—Etoposide—sarcoma	0.000683	0.00167	CcSEcCtD
Hydralazine—Anaemia—Epirubicin—sarcoma	0.000682	0.00167	CcSEcCtD
Hydralazine—Agitation—Epirubicin—sarcoma	0.000678	0.00166	CcSEcCtD
Hydralazine—Rash—Etoposide—sarcoma	0.000678	0.00166	CcSEcCtD
Hydralazine—Dermatitis—Etoposide—sarcoma	0.000677	0.00166	CcSEcCtD
Hydralazine—Headache—Etoposide—sarcoma	0.000673	0.00165	CcSEcCtD
Hydralazine—Malaise—Epirubicin—sarcoma	0.000666	0.00163	CcSEcCtD
Hydralazine—Leukopenia—Epirubicin—sarcoma	0.000661	0.00162	CcSEcCtD
Hydralazine—Muscle spasms—Doxorubicin—sarcoma	0.000657	0.00161	CcSEcCtD
Hydralazine—Palpitations—Epirubicin—sarcoma	0.000652	0.0016	CcSEcCtD
Hydralazine—Nausea—Etoposide—sarcoma	0.000638	0.00156	CcSEcCtD
Hydralazine—Ill-defined disorder—Doxorubicin—sarcoma	0.000634	0.00155	CcSEcCtD
Hydralazine—Anaemia—Doxorubicin—sarcoma	0.000631	0.00154	CcSEcCtD
Hydralazine—Myalgia—Epirubicin—sarcoma	0.000629	0.00154	CcSEcCtD
Hydralazine—Arthralgia—Epirubicin—sarcoma	0.000629	0.00154	CcSEcCtD
Hydralazine—Agitation—Doxorubicin—sarcoma	0.000628	0.00154	CcSEcCtD
Hydralazine—Anxiety—Epirubicin—sarcoma	0.000626	0.00153	CcSEcCtD
Hydralazine—Discomfort—Epirubicin—sarcoma	0.000621	0.00152	CcSEcCtD
Hydralazine—Malaise—Doxorubicin—sarcoma	0.000616	0.00151	CcSEcCtD
Hydralazine—Leukopenia—Doxorubicin—sarcoma	0.000611	0.0015	CcSEcCtD
Hydralazine—Palpitations—Doxorubicin—sarcoma	0.000604	0.00148	CcSEcCtD
Hydralazine—Oedema—Epirubicin—sarcoma	0.000603	0.00147	CcSEcCtD
Hydralazine—Thrombocytopenia—Epirubicin—sarcoma	0.00059	0.00144	CcSEcCtD
Hydralazine—Tachycardia—Epirubicin—sarcoma	0.000588	0.00144	CcSEcCtD
Hydralazine—Arthralgia—Doxorubicin—sarcoma	0.000582	0.00142	CcSEcCtD
Hydralazine—Myalgia—Doxorubicin—sarcoma	0.000582	0.00142	CcSEcCtD
Hydralazine—Anxiety—Doxorubicin—sarcoma	0.00058	0.00142	CcSEcCtD
Hydralazine—Discomfort—Doxorubicin—sarcoma	0.000575	0.00141	CcSEcCtD
Hydralazine—Anorexia—Epirubicin—sarcoma	0.000574	0.0014	CcSEcCtD
Hydralazine—Hypotension—Epirubicin—sarcoma	0.000563	0.00138	CcSEcCtD
Hydralazine—Oedema—Doxorubicin—sarcoma	0.000558	0.00136	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000549	0.00134	CcSEcCtD
Hydralazine—Thrombocytopenia—Doxorubicin—sarcoma	0.000546	0.00134	CcSEcCtD
Hydralazine—Tachycardia—Doxorubicin—sarcoma	0.000544	0.00133	CcSEcCtD
Hydralazine—Paraesthesia—Epirubicin—sarcoma	0.000541	0.00132	CcSEcCtD
Hydralazine—Dyspnoea—Epirubicin—sarcoma	0.000537	0.00131	CcSEcCtD
Hydralazine—Anorexia—Doxorubicin—sarcoma	0.000531	0.0013	CcSEcCtD
Hydralazine—Dyspepsia—Epirubicin—sarcoma	0.00053	0.0013	CcSEcCtD
Hydralazine—Decreased appetite—Epirubicin—sarcoma	0.000524	0.00128	CcSEcCtD
Hydralazine—Hypotension—Doxorubicin—sarcoma	0.000521	0.00127	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Epirubicin—sarcoma	0.00052	0.00127	CcSEcCtD
Hydralazine—Constipation—Epirubicin—sarcoma	0.000515	0.00126	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000508	0.00124	CcSEcCtD
Hydralazine—Paraesthesia—Doxorubicin—sarcoma	0.000501	0.00122	CcSEcCtD
Hydralazine—Dyspnoea—Doxorubicin—sarcoma	0.000497	0.00122	CcSEcCtD
Hydralazine—Feeling abnormal—Epirubicin—sarcoma	0.000497	0.00121	CcSEcCtD
Hydralazine—Dyspepsia—Doxorubicin—sarcoma	0.000491	0.0012	CcSEcCtD
Hydralazine—Decreased appetite—Doxorubicin—sarcoma	0.000485	0.00119	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000481	0.00118	CcSEcCtD
Hydralazine—Urticaria—Epirubicin—sarcoma	0.000479	0.00117	CcSEcCtD
Hydralazine—Constipation—Doxorubicin—sarcoma	0.000477	0.00117	CcSEcCtD
Hydralazine—Body temperature increased—Epirubicin—sarcoma	0.000476	0.00117	CcSEcCtD
Hydralazine—Feeling abnormal—Doxorubicin—sarcoma	0.000459	0.00112	CcSEcCtD
Hydralazine—Hypersensitivity—Epirubicin—sarcoma	0.000444	0.00109	CcSEcCtD
Hydralazine—Urticaria—Doxorubicin—sarcoma	0.000443	0.00108	CcSEcCtD
Hydralazine—Body temperature increased—Doxorubicin—sarcoma	0.000441	0.00108	CcSEcCtD
Hydralazine—Pruritus—Epirubicin—sarcoma	0.000426	0.00104	CcSEcCtD
Hydralazine—Diarrhoea—Epirubicin—sarcoma	0.000412	0.00101	CcSEcCtD
Hydralazine—Hypersensitivity—Doxorubicin—sarcoma	0.000411	0.001	CcSEcCtD
Hydralazine—Dizziness—Epirubicin—sarcoma	0.000398	0.000975	CcSEcCtD
Hydralazine—Pruritus—Doxorubicin—sarcoma	0.000394	0.000965	CcSEcCtD
Hydralazine—Vomiting—Epirubicin—sarcoma	0.000383	0.000937	CcSEcCtD
Hydralazine—Diarrhoea—Doxorubicin—sarcoma	0.000381	0.000933	CcSEcCtD
Hydralazine—Rash—Epirubicin—sarcoma	0.00038	0.000929	CcSEcCtD
Hydralazine—Dermatitis—Epirubicin—sarcoma	0.00038	0.000928	CcSEcCtD
Hydralazine—Headache—Epirubicin—sarcoma	0.000377	0.000923	CcSEcCtD
Hydralazine—Dizziness—Doxorubicin—sarcoma	0.000369	0.000902	CcSEcCtD
Hydralazine—Nausea—Epirubicin—sarcoma	0.000358	0.000875	CcSEcCtD
Hydralazine—Vomiting—Doxorubicin—sarcoma	0.000354	0.000867	CcSEcCtD
Hydralazine—Rash—Doxorubicin—sarcoma	0.000352	0.00086	CcSEcCtD
Hydralazine—Dermatitis—Doxorubicin—sarcoma	0.000351	0.000859	CcSEcCtD
Hydralazine—Headache—Doxorubicin—sarcoma	0.000349	0.000854	CcSEcCtD
Hydralazine—Nausea—Doxorubicin—sarcoma	0.000331	0.00081	CcSEcCtD
